Blood-Cancer.com
is conducting a market research study on behalf of a sponsor, to get feedback
from people living with myelofibrosis on new education materials.
Click
Here to See if You Qualify
If you complete the screening survey and qualify for the study, you may be
asked to participate in a 60-minute interview, which would be scheduled at your
convenience. At the time of the interview, you will be asked to be at a
computer with an internet connection so that the moderator can share materials
for you to review. You will also need access to a phone that will use audio
during the interview.
If you complete the screening survey, qualify for the study, are selected to
participate, and participate fully, you will receive an incentive of a $100 gift card.
Since we are looking for specific patients, we will first ask you a few questions
to determine if you qualify. You may be eligible to participate in the study
and earn the gift card if you:
- Are
18 years of age or older
- Are
a US resident
- Have
been diagnosed with myelofibrosis
- Regularly
receive red blood cell transfusions
Click
Here to See if You Qualify
About Blood-Cancer.com Market
Research:
Blood-Cancer.com occasionally
conducts custom research studies for companies interested in learning more
about how patients feel about their products or services.
Please know that:
- We
will always let you know when a survey is for a market research sponsor.
- Participation
in market research is completely optional.
- Research
opportunities are limited to a set number of participants, and
participation is on a first-come, first-served basis.
- Participants
need to meet certain criteria to participate in a survey and receive the
gift card. If you do not qualify and complete study participation, you
will not receive the gift card.
- In
some cases, our recruitment team may contact you to verify your responses.
- We
take your privacy seriously. Your personal information is stored in a
secure system and will never
be shared with the sponsor.
Questions? Email us at Research@Blood-Cancer.com
No comments:
Post a Comment